FibroBiologics (FBLG) Market Capitalization (2024 - 2026)

FibroBiologics (FBLG) has reported Market Capitalization for 3 consecutive years, with $6.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 75.72% year-over-year to $6.3 million; the trailing twelve-month figure through Jun 2026 stood at $6.3 million (down 75.72% YoY), and the FY2025 full-year result was $15.0 million, down 80.17% from the prior year.
• Market Capitalization climbed to $6.3 million in Q2 2026 per FBLG's latest filing, from $5.0 million in the prior quarter.
• Across five years, Market Capitalization topped out at $353.7 million in Q1 2024 and bottomed at $5.0 million in Q1 2026.
• Historically, Market Capitalization has averaged $82.7 million across 3 years, with a median of $31.3 million in 2025.
• The widest YoY moves for Market Capitalization: up 73.77% in 2025, down 90.26% in 2025.
• Over 3 years, Market Capitalization stood at $75.5 million in 2024, then plunged by 80.17% to $15.0 million in 2025, then slumped by 57.74% to $6.3 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $6.3 million, $5.0 million, and $15.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.